DVA DaVita
too hard · 68
Owner-earnings value$233.02
Price$180.06
Margin of safety
+29.4%
Quality gate · 68/100
⚠ negative book equity · over-levered (net debt/EBITDA 4.5x > 4x)
Median ROIC14.4%
Gross margin32.4%
Net debt / EBITDA4.5x
FCF conversion178%
Share count / yr-8.8%
Profitable years4/4
Moat & management
Owner-earnings inputs
| Owner earnings (TTM) | 963.52M |
| Owner-earnings yield | 8.3% |
| Free-cash-flow yield | 12.9% |
| Growth used (normalized) | 0.5% |
| Market-implied growth (reverse DCF) | -5.5% |
| Terminal growth | 3.0% |
| Discount rate (hurdle) | 9.0% |
Projected owner earnings
| Yr | Owner earnings | Growth | PV |
|---|---|---|---|
| 1 | 968.11M | 0.5% | 888.17M |
| 2 | 975.44M | 0.8% | 821.01M |
| 3 | 985.56M | 1.0% | 761.03M |
| 4 | 998.54M | 1.3% | 707.39M |
| 5 | 1.01B | 1.6% | 659.36M |
| 6 | 1.03B | 1.9% | 616.28M |
| 7 | 1.06B | 2.2% | 577.60M |
| 8 | 1.08B | 2.4% | 542.83M |
| 9 | 1.11B | 2.7% | 511.55M |
| 10 | 1.14B | 3.0% | 483.40M |
Recent news
score · 8 articles
- 3 Reasons to Sell DVA and 1 Stock to Buy Instead
- Why Is Encompass Health (EHC) Down 1.8% Since Last Earnings Report?
- 3 of Wall Street’s Favorite Stocks We Find Risky
- DaVita (DVA) Has Investors Asking A Fresh Question
- Can Fresenius Medical's 5008X Rollout Drive the Next Growth Phase?
- Why Is DaVita HealthCare (DVA) Down 4.9% Since Last Earnings Report?
- Do Options Traders Know Something About DaVita Stock We Don't?
- 1 Value Stock to Target This Week and 2 We Find Risky
⚠ maintenance capex ≈ min(capex, D&A), capped at FCF · Price pays for ~-6%/yr owner-earnings growth over 10y (reverse DCF); model credits 0%. Capped at market + 6pts.